Dendreon (DNDN) Enters Agreement With Henderson Corp of PA
Last week, on June 16th, Dendreon Corporation (Nasdaq: DNDN) entered into a Construction Agreement between The Henderson Corporation of PA, Inc. and Dendreon to retain Henderson to perform construction related services and to arrange for, monitor, supervise, administer and contract for the construction of Phase II and Phase III of Dendreon’s therapeutic biotechnology processing facility in Morris Plains, New Jersey.
Phase II, which consists of additional quality control laboratories, data center, training areas, infrastructure and offices, is to be substantially complete by December 18, 2009. Phase III, which consists of additional manufacturing clean room work stations, production support areas, warehouse, infrastructure and offices, is to be substantially complete by April 23, 2010. There are incentives included in the Agreement for the completion of work prior to such dates and penalties for failing to meet such deadlines. The guaranteed maximum price for the completion of all work under the Agreement is approximately $50.5 million.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Phase II, which consists of additional quality control laboratories, data center, training areas, infrastructure and offices, is to be substantially complete by December 18, 2009. Phase III, which consists of additional manufacturing clean room work stations, production support areas, warehouse, infrastructure and offices, is to be substantially complete by April 23, 2010. There are incentives included in the Agreement for the completion of work prior to such dates and penalties for failing to meet such deadlines. The guaranteed maximum price for the completion of all work under the Agreement is approximately $50.5 million.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
You May Also Be Interested In
- UPDATE: Patriot Coal (PCX) Continues to Work with Lenders to Strengthen Financing, Hired Blackstone
- Golden Star Resources (GSS) Comments on Recent Market Activity; No Material Info Undisclosed
- Health Canada Accepts Seattle Genetics' (SGEN) ADCETRIS NDS for REview
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
